Resources

Webinar

Staying Ahead in 340B: Update on Latest Developments,Trends and Predictions for Remainder of 2026 Webinar

July 27, 2026

Blog

How Leading Biopharma Organizations Are Preparing for the Next Era of Commercialization

Podcast

340B Podcast Series, Episode 2: Rebate Model with Clay Willis

White Paper

340B Program Update: Rebate Model, Contract Pharmacies, Duplicate Discounts, and What Manufacturers Need to Know

Podcast

340B Podcast Series, Episode 1: All Claims Collection with Clay Willis

White Paper

The Specialty Patent Cliff and the Payer Response

Webinar

Transitioning Away From Affordability Programs After Launch Webinar

June 16, 2026

Blog

Channel Evolution: When Does Direct-to-Patient Become Relevant for Specialty Pharmaceuticals?

Blog

Rethinking Cash’s Role in Your Market Access Strategy

Webinar

Commercial Readiness for Clinical-Stage Companies: Policy & Market Crosscurrents Redefining Biopharma Launch Success Webinar

June 4, 2026

Blog

From Reactive to Proactive: How Drug Manufacturers Can Stay Ahead of Federal and State Reporting Requirements

Resource

340B Program Update: Rebate Model, Contract Pharmacies, Duplicate Discounts, and What Manufacturers Need to Know